Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Schouten

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Bone Marrow Transplantation|September 9, 2008
The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCTS McCann, M Schwenkglenks, P Bacon, et al.
Bone Marrow Transplantation|April 20, 2010
Prognostic factors and outcome in relapsed multiple myeloma after nonmyeloablative allo-SCT: a single center experienceM C Minnema, S van Dorp, N W C J van de Donk, et al.
Annals of the Rheumatic Diseases|April 18, 2002
Work status and productivity costs due to ankylosing spondylitis: comparison of three European countriesA Boonen, D van der Heijde, R Landewé, et al.
Annals of the Rheumatic Diseases|July 16, 2003
Costs of ankylosing spondylitis in three European countries: the patient's perspectiveA Boonen, D van der Heijde, R Landewé, et al.
Blood|November 5, 1997
Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia: final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer and the Dutch Belgian Hemato-Oncology Cooperative GroupB Löwenberg, S Suciu, E Archimbaud, et al.
International Journal of Oral and Maxillofacial Surgery|June 2, 2021
Patient- and clinician-reported outcomes for the additively manufactured sub-periosteal jaw implant (AMSJI) in the maxilla: a prospective multicentre one-year follow-up studyC Van den Borre, M Rinaldi, B De Neef, et al.
Annals of the Rheumatic Diseases|July 16, 2003
Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countriesA Boonen, D van der Heijde, R Landewé, et al.
Bone Marrow Transplantation|January 31, 2006
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in EuropeP Ljungman, A Urbano-Ispizua, M Cavazzana-Calvo, et al.
Bone Marrow Transplantation|July 9, 2009
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009P Ljungman, M Bregni, M Brune, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2016
Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT†S P Robinson, A Boumendil, H Finel, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Bone Marrow Transplantation|September 9, 2008
The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCTS McCann, M Schwenkglenks, P Bacon, et al.
Bone Marrow Transplantation|April 20, 2010
Prognostic factors and outcome in relapsed multiple myeloma after nonmyeloablative allo-SCT: a single center experienceM C Minnema, S van Dorp, N W C J van de Donk, et al.
Annals of the Rheumatic Diseases|April 18, 2002
Work status and productivity costs due to ankylosing spondylitis: comparison of three European countriesA Boonen, D van der Heijde, R Landewé, et al.
Annals of the Rheumatic Diseases|July 16, 2003
Costs of ankylosing spondylitis in three European countries: the patient's perspectiveA Boonen, D van der Heijde, R Landewé, et al.
Blood|November 5, 1997
Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia: final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer and the Dutch Belgian Hemato-Oncology Cooperative GroupB Löwenberg, S Suciu, E Archimbaud, et al.
International Journal of Oral and Maxillofacial Surgery|June 2, 2021
Patient- and clinician-reported outcomes for the additively manufactured sub-periosteal jaw implant (AMSJI) in the maxilla: a prospective multicentre one-year follow-up studyC Van den Borre, M Rinaldi, B De Neef, et al.
Annals of the Rheumatic Diseases|July 16, 2003
Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countriesA Boonen, D van der Heijde, R Landewé, et al.
Bone Marrow Transplantation|January 31, 2006
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in EuropeP Ljungman, A Urbano-Ispizua, M Cavazzana-Calvo, et al.
Bone Marrow Transplantation|July 9, 2009
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009P Ljungman, M Bregni, M Brune, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2016
Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT†S P Robinson, A Boumendil, H Finel, et al.
Pageof 4